Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP7746)
Name
Omega-3 PUFAs
Species Origin phytoplankton environmental sample ...     Click to Show/Hide
phytoplankton environmental sample
SuperKingdom: Eukaryota
Species: phytoplankton environmental sample
Disease Periodontal disease [ICD-11: DA0C] Phase 4 [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Naproxen      Osteoarthritis     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression VCAM1  Molecule Info 
Pathway MAP
                    Biological
                    Regulation
Decrease Serum TG
                    In-vivo Model Clinical trial
                    Experimental
                    Result(s)
Combining NX with omega-3 PUFAs increases their effectiveness in reducing serum TG and favorably altering AT gene expression and plasma bile acid profile.
          Proanthocyanidins      Atherosclerosis     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [3]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Biological
                    Regulation
Down-regulation Bifidobacterium secretion
Up-regulation Lactobacillus secretion
                    In-vivo Model A total of twenty-eight female Wistar-Kyoto rats aged 8-10 weeks were used in this study.
                    Experimental
                    Result(s)
Combined supplementation of Omega-3 PUFAs and proanthocyanidins from grape seed counteracts the effects of the Omega-3 PUFAs on health-promoting lactobacillus and bifidobacterium, and on acetic acid, while maintaining their beneficial effects on cholesterolemia.
References
Reference 1 ClinicalTrials.gov (NCT01997853) Omega-3 Fatty Acids in Chronic Periodontitis.
Reference 2 A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation. J Diabetes Complications. 2020 Feb;34(2):107494.
Reference 3 Effects of the combination of Omega-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats. Food Res Int. 2017 Jul;97:364-371.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China